NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL was reported 3223 times

NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTERIOR CHAMBER ANGLE NEOVASCULARISATION 1 0.2000
1 BRACHIORADIAL PRURITUS 1 0.0667
2 BIOPSY ENDOMETRIUM ABNORMAL 1 0.0385
3 GRIP STRENGTH 5 0.0218
4 BREAST FIBROMA 1 0.0208
5 ADJUSTMENT DISORDER WITH ANXIETY 1 0.0147
6 ACQUIRED PORPHYRIA 1 0.0141
7 ADMINISTRATION SITE ODOUR 1 0.0132
8 EXPOSURE TO ALLERGEN 4 0.0125
9 FAILED INDUCTION OF LABOUR 2 0.0103
10 AMINO ACID LEVEL ABNORMAL 1 0.0103
11 AUTOIMMUNE THYROID DISORDER 1 0.0092
12 VAGINAL LACERATION 2 0.0092
13 BLOOD GROWTH HORMONE ABNORMAL 1 0.0082
14 SWOLLEN JOINT COUNT 2 0.0080
15 TRANSVERSE SINUS THROMBOSIS 4 0.0076
16 CERVICOGENIC HEADACHE 1 0.0074
17 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 1 0.0068
18 GINGIVAL ABSCESS 5 0.0066
19 ACOUSTIC STIMULATION TESTS ABNORMAL 1 0.0064
20 AMINO ACID LEVEL DECREASED 2 0.0059
21 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 8 0.0059
22 CHONDRITIS 1 0.0057
23 ACANTHOSIS NIGRICANS 1 0.0054
24 POLYCYSTIC OVARIAN SYNDROME 2 0.0052
25 GLUTEN SENSITIVITY 7 0.0049
26 ANOVULATORY CYCLE 1 0.0048
27 ANTIDEPRESSANT DISCONTINUATION SYNDROME 1 0.0048
28 BREAST ATROPHY 1 0.0045
29 STATUS ASTHMATICUS 2 0.0042
30 ARRESTED LABOUR 1 0.0042
31 BODY MASS INDEX ABNORMAL 1 0.0041
32 ADENOTONSILLECTOMY 1 0.0040
33 CATHETER SITE THROMBOSIS 1 0.0036
34 SCIATIC NERVE INJURY 3 0.0036
35 COLECTOMY TOTAL 2 0.0036
36 CERVIX CARCINOMA STAGE 0 1 0.0035
37 BACTERIAL VULVOVAGINITIS 1 0.0035
38 ALLERGY TO ARTHROPOD BITE 1 0.0031
39 SOCIAL ANXIETY DISORDER 2 0.0030
40 CATHETER SITE IRRITATION 1 0.0030
41 BLOOD OESTROGEN DECREASED 2 0.0028
42 ALLERGY TO ANIMAL 3 0.0028
43 INTRACRANIAL VENOUS SINUS THROMBOSIS 3 0.0028
44 WITHDRAWAL BLEED 2 0.0027
45 BREATH HOLDING 1 0.0026
46 GALLBLADDER POLYP 2 0.0025
47 CLUBBING 1 0.0025
48 LUPUS VULGARIS 3 0.0024
49 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
50 BILIARY DYSKINESIA 4 0.0024
51 LIP PRURITUS 2 0.0023
52 PREGNANCY ON ORAL CONTRACEPTIVE 6 0.0023
53 ALLERGY TO PLANTS 1 0.0022
54 PREMENSTRUAL SYNDROME 3 0.0022
55 ANASTOMOTIC ULCER 1 0.0022
56 FACET JOINT SYNDROME 7 0.0021
57 INTERMENSTRUAL BLEEDING 12 0.0021
58 SLEEP-RELATED EATING DISORDER 2 0.0021
59 CATAPLEXY 3 0.0021
60 POLYMENORRHOEA 7 0.0020
61 DEEP VEIN THROMBOSIS POSTOPERATIVE 4 0.0020
62 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 4 0.0019
63 AUTOSCOPY 1 0.0019
64 METRORRHAGIA 31 0.0018
65 BLOOD GROWTH HORMONE INCREASED 1 0.0018
66 INFECTIOUS MONONUCLEOSIS 4 0.0018
67 STRESS AT WORK 2 0.0018
68 DISLOCATION OF VERTEBRA 4 0.0018
69 BURN ORAL CAVITY 1 0.0017
70 RETINITIS 3 0.0017
71 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE 1 0.0017
72 MENOPAUSAL SYMPTOMS 4 0.0017
73 INFUSION SITE DISCHARGE 3 0.0017
74 TERMINAL INSOMNIA 3 0.0017
75 ADENOMYOSIS 1 0.0017
76 X-RAY ABNORMAL 3 0.0017
77 THROMBOPHLEBITIS SUPERFICIAL 5 0.0016
78 ALLERGY TO METALS 1 0.0016
79 TOOTH EROSION 2 0.0016
80 BAND SENSATION 2 0.0016
81 ADNEXA UTERI PAIN 2 0.0016
82 LACTOSE INTOLERANCE 4 0.0016
83 ABDOMINAL OPERATION 2 0.0015
84 WISDOM TEETH REMOVAL 2 0.0015
85 CHOLECYSTITIS CHRONIC 10 0.0015
86 SKIN DISCOMFORT 4 0.0015
87 VULVOVAGINAL CANDIDIASIS 2 0.0015
88 ENDOMETRIOSIS 7 0.0015
89 H1N1 INFLUENZA 2 0.0014
90 ALCOHOL INTOLERANCE 1 0.0014
91 PORPHYRIA ACUTE 2 0.0014
92 NOROVIRUS INFECTION 2 0.0014
93 MENSTRUATION IRREGULAR 37 0.0014
94 BILIARY COLIC 4 0.0014
95 GENERALISED ANXIETY DISORDER 2 0.0014
96 SKIN STRIAE 2 0.0013
97 INFUSION SITE REACTION 4 0.0013
98 EPICONDYLITIS 2 0.0013
99 COELIAC DISEASE 13 0.0013
100 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
101 RUBBER SENSITIVITY 2 0.0013
102 POLYCYSTIC OVARIES 2 0.0013
103 COITAL BLEEDING 2 0.0013
104 PRE-EXISTING CONDITION IMPROVED 8 0.0013
105 SWOLLEN JOINT COUNT INCREASED 4 0.0013
106 CUSHINGOID 4 0.0012
107 PULMONARY ARTERIAL PRESSURE INCREASED 2 0.0012
108 MENSTRUATION DELAYED 13 0.0012
109 ANXIETY DISORDER 4 0.0012
110 VASODILATATION 3 0.0012
111 ATONIC SEIZURES 1 0.0012
112 ABSCESS DRAINAGE 1 0.0012
113 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
114 VERTIGO POSITIONAL 2 0.0011
115 BONE EROSION 4 0.0011
116 JUGULAR VEIN THROMBOSIS 2 0.0011
117 DERMATITIS ATOPIC 59 0.0011
118 BREAST SWELLING 3 0.0011
119 CATHETER MANAGEMENT 1 0.0011
120 HEAVY MENSTRUAL BLEEDING 10 0.0011
121 BIOPSY 1 0.0011
122 ADVERSE FOOD REACTION 1 0.0011
123 TUNNEL VISION 2 0.0011
124 BREAST TENDERNESS 8 0.0011
125 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 18 0.0011
126 NARCOLEPSY 2 0.0011
127 DYSMENORRHOEA 14 0.0011
128 POST-TRAUMATIC STRESS DISORDER 7 0.0010
129 VITAMIN B12 DECREASED 3 0.0010
130 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
131 GALLBLADDER INJURY 2 0.0010
132 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
133 MENORRHAGIA 20 0.0010
134 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
135 ACNE CYSTIC 3 0.0010
136 REBOUND ACID HYPERSECRETION 3 0.0010
137 PERIPHERAL VENOUS DISEASE 4 0.0010
138 CHANGE OF BOWEL HABIT 2 0.0010
139 BREAST DISCOMFORT 1 0.0010
140 MENSTRUAL DISORDER 8 0.0010
141 INFUSION SITE PRURITUS 3 0.0009
142 INFUSION SITE ERYTHEMA 8 0.0009
143 BONE DEMINERALISATION 1 0.0009
144 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
145 FEELING DRUNK 7 0.0009
146 UTERINE HAEMORRHAGE 4 0.0009
147 GASTRIC CANCER STAGE IV 2 0.0009
148 BLOOD TESTOSTERONE INCREASED 2 0.0009
149 BINGE EATING 1 0.0009
150 VULVOVAGINAL DRYNESS 3 0.0009
151 PERIODONTITIS 2 0.0009
152 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 5 0.0009
153 CERVICAL DYSPLASIA 2 0.0009
154 GRIP STRENGTH DECREASED 8 0.0009
155 MIDDLE EAR EFFUSION 2 0.0009
156 BURSITIS 11 0.0009
157 PRODUCT LOT NUMBER ISSUE 2 0.0009
158 LYME DISEASE 3 0.0009
159 RHEUMATIC FEVER 4 0.0009
160 CATHETER SITE DISCHARGE 1 0.0009
161 BENIGN NEOPLASM 1 0.0009
162 EXOSTOSIS 8 0.0009
163 READING DISORDER 2 0.0009
164 VAGINAL HAEMORRHAGE 38 0.0009
165 DYSPAREUNIA 4 0.0009
166 REACTION TO EXCIPIENT 2 0.0009
167 DISTURBANCE IN SOCIAL BEHAVIOUR 2 0.0008
168 PAINFUL RESPIRATION 2 0.0008
169 INFLAMMATORY BOWEL DISEASE 8 0.0008
170 DUODENAL ULCER PERFORATION 6 0.0008
171 HYPERACUSIS 3 0.0008
172 INFUSION SITE SWELLING 5 0.0008
173 CHOLECYSTECTOMY 9 0.0008
174 C-REACTIVE PROTEIN ABNORMAL 5 0.0008
175 INJECTION SITE URTICARIA 19 0.0008
176 WALKING AID USER 5 0.0008
177 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
178 TRIGEMINAL NEURALGIA 3 0.0007
179 ANAL ABSCESS 4 0.0007
180 AMENORRHOEA 13 0.0007
181 WRONG PRODUCT ADMINISTERED 5 0.0007
182 PHARYNGITIS STREPTOCOCCAL 8 0.0007
183 LARGE INTESTINAL ULCER 2 0.0007
184 SKIN WRINKLING 2 0.0007
185 CLUMSINESS 2 0.0007
186 DEMYELINATION 3 0.0007
187 CLUSTER HEADACHE 1 0.0007
188 AGORAPHOBIA 1 0.0007
189 DRUG SCREEN FALSE POSITIVE 2 0.0007
190 CARDIOVERSION 1 0.0007
191 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
192 APPENDIX DISORDER 1 0.0007
193 RHEUMATOID FACTOR POSITIVE 4 0.0007
194 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
195 HELICOBACTER INFECTION 7 0.0007
196 COCCYDYNIA 1 0.0007
197 PRODUCT SUBSTITUTION ISSUE 39 0.0007
198 ANKLE OPERATION 1 0.0007
199 AXILLARY PAIN 1 0.0007
200 LOSS OF EMPLOYMENT 2 0.0007
201 INJECTION SITE PAPULE 3 0.0007
202 MASTICATION DISORDER 2 0.0007
203 EYELIDS PRURITUS 2 0.0006
204 EAR INFECTION 17 0.0006
205 RESPIRATORY RATE DECREASED 2 0.0006
206 AFFECTIVE DISORDER 5 0.0006
207 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
208 PHOTOPSIA 4 0.0006
209 FOOT DEFORMITY 7 0.0006
210 HYPERCHOLESTEROLAEMIA 6 0.0006
211 BREAST CANCER STAGE III 4 0.0006
212 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
213 HORMONE LEVEL ABNORMAL 3 0.0006
214 LYMPHOCYTE COUNT INCREASED 2 0.0006
215 BRADYPHRENIA 4 0.0006
216 BREAST ENLARGEMENT 2 0.0006
217 SOMNAMBULISM 4 0.0006
218 NASAL POLYPS 3 0.0006
219 EMBEDDED DEVICE 6 0.0006
220 MUCOUS STOOLS 3 0.0006
221 POOR QUALITY SLEEP 13 0.0006
222 INJECTION SITE INFLAMMATION 3 0.0006
223 BLOOD CALCIUM ABNORMAL 1 0.0006
224 VULVOVAGINAL PRURITUS 3 0.0006
225 MIDDLE INSOMNIA 11 0.0006
226 INITIAL INSOMNIA 6 0.0006
227 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
228 ACUTE SINUSITIS 1 0.0006
229 SKIN SWELLING 5 0.0006
230 FOLLICULITIS 6 0.0006
231 EAR PRURITUS 2 0.0006
232 BREAST CYST 1 0.0006
233 MACULOPATHY 2 0.0006
234 BREAST PAIN 6 0.0006
235 APPENDICECTOMY 2 0.0006
236 ANAL FISSURE 3 0.0006
237 DEVICE PLACEMENT ISSUE 2 0.0006
238 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4 0.0006
239 CEREBRAL VENOUS THROMBOSIS 1 0.0006
240 PULMONARY THROMBOSIS 6 0.0005
241 MAJOR DEPRESSION 4 0.0005
242 MIGRAINE 52 0.0005
243 BODY TEMPERATURE ABNORMAL 1 0.0005
244 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
245 CYSTIC FIBROSIS 3 0.0005
246 AURA 1 0.0005
247 BLADDER SPASM 1 0.0005
248 THROAT CLEARING 2 0.0005
249 BLOOD IRON INCREASED 1 0.0005
250 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
251 ABORTION INDUCED 5 0.0005
252 PERIORBITAL SWELLING 3 0.0005
253 AUTOIMMUNE THYROIDITIS 2 0.0005
254 PRODUCT STORAGE ISSUE 2 0.0005
255 NIGHT SWEATS 17 0.0005
256 BONE MARROW TRANSPLANT 1 0.0005
257 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
258 ATROPHY 1 0.0005
259 RHINOVIRUS INFECTION 2 0.0005
260 AUTOIMMUNE DISORDER 5 0.0005
261 URINE ODOUR ABNORMAL 3 0.0005
262 VULVOVAGINAL MYCOTIC INFECTION 2 0.0005
263 BODY TEMPERATURE DECREASED 5 0.0005
264 MOOD SWINGS 16 0.0005
265 PELVIC PAIN 9 0.0005
266 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
267 INTENTIONAL DOSE OMISSION 14 0.0005
268 HYPERAESTHESIA 4 0.0005
269 IMPAIRED QUALITY OF LIFE 7 0.0005
270 CHOLANGITIS SCLEROSING 1 0.0005
271 HYPOKINESIA 7 0.0005
272 ANAL PRURITUS 1 0.0005
273 THYROID FUNCTION TEST ABNORMAL 2 0.0005
274 TENDERNESS 5 0.0005
275 SLEEP TERROR 2 0.0005
276 SLEEP APNOEA SYNDROME 9 0.0005
277 PURULENT DISCHARGE 2 0.0005
278 CD4 LYMPHOCYTES DECREASED 1 0.0005
279 INFUSION SITE PAIN 6 0.0005
280 ABSCESS INTESTINAL 1 0.0005
281 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
282 PARANOIA 8 0.0005
283 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
284 BIPOLAR DISORDER 5 0.0005
285 HAND DEFORMITY 6 0.0005
286 PULMONARY FUNCTION TEST DECREASED 2 0.0005
287 MELANOCYTIC NAEVUS 2 0.0005
288 BIPOLAR I DISORDER 1 0.0005
289 THIRST 8 0.0004
290 IMPLANT SITE PAIN 2 0.0004
291 BREAST MASS 3 0.0004
292 DISEASE RECURRENCE 21 0.0004
293 LIP DRY 4 0.0004
294 IMPAIRED GASTRIC EMPTYING 6 0.0004
295 ECZEMA 23 0.0004
296 SCIATICA 7 0.0004
297 INJECTION SITE WARMTH 9 0.0004
298 RESPIRATION ABNORMAL 3 0.0004
299 APHTHOUS STOMATITIS 1 0.0004
300 PRODUCT DISTRIBUTION ISSUE 4 0.0004
301 FORMICATION 3 0.0004
302 MADAROSIS 5 0.0004
303 HUNGER 6 0.0004
304 SINUSITIS 44 0.0004
305 YELLOW SKIN 2 0.0004
306 SEASONAL ALLERGY 6 0.0004
307 BLOOD IRON DECREASED 5 0.0004
308 PRODUCT PACKAGING ISSUE 4 0.0004
309 IRRITABLE BOWEL SYNDROME 9 0.0004
310 INJECTION SITE PRURITUS 28 0.0004
311 VULVOVAGINAL PAIN 2 0.0004
312 GUILLAIN-BARRE SYNDROME 2 0.0004
313 PRODUCT DISPENSING ERROR 9 0.0004
314 FAECES SOFT 3 0.0004
315 SKIN FISSURES 8 0.0004
316 VITREOUS FLOATERS 4 0.0004
317 CARTILAGE INJURY 1 0.0004
318 ARTHROPOD BITE 3 0.0004
319 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
320 INJECTION SITE SWELLING 31 0.0004
321 MOOD ALTERED 11 0.0004
322 GLOSSODYNIA 9 0.0004
323 PROTEIN URINE PRESENT 2 0.0004
324 PAROSMIA 3 0.0004
325 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
326 INSURANCE ISSUE 6 0.0004
327 ABNORMAL UTERINE BLEEDING 1 0.0004
328 FOOD ALLERGY 3 0.0004
329 TEMPERATURE INTOLERANCE 4 0.0004
330 TRISMUS 2 0.0004
331 VARICOSE VEIN 2 0.0004
332 APHTHOUS ULCER 3 0.0004
333 CATHETER SITE PAIN 1 0.0004
334 HOT FLUSH 29 0.0004
335 INJURY 27 0.0004
336 MULTIPLE ALLERGIES 3 0.0004
337 DRY EYE 19 0.0004
338 PHARYNGOLARYNGEAL PAIN 2 0.0004
339 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
340 ABDOMINAL DISTENSION 39 0.0004
341 JOINT RANGE OF MOTION DECREASED 5 0.0004
342 HEREDITARY ANGIOEDEMA 4 0.0004
343 QUALITY OF LIFE DECREASED 5 0.0004
344 PHOTOPHOBIA 7 0.0004
345 BRUXISM 2 0.0004
346 FIBROMYALGIA 9 0.0004
347 CLONUS 1 0.0004
348 WOUND INFECTION 4 0.0004
349 ASTHENOPIA 2 0.0004
350 INJECTION SITE BRUISING 29 0.0004
351 DEAFNESS UNILATERAL 2 0.0004
352 MUSCLE INJURY 3 0.0004
353 DISCOMFORT 22 0.0004
354 STREPTOCOCCAL INFECTION 2 0.0004
355 EMOTIONAL DISORDER 11 0.0004
356 OCULAR DISCOMFORT 4 0.0004
357 ABDOMINAL PAIN LOWER 9 0.0004
358 UTERINE PERFORATION 3 0.0004
359 CEREBRAL THROMBOSIS 1 0.0004
360 CHOLECYSTITIS ACUTE 2 0.0004
361 PRODUCT DOSE OMISSION 23 0.0004
362 PERONEAL NERVE PALSY 2 0.0004
363 EYE SWELLING 13 0.0003
364 INJECTION SITE REACTION 24 0.0003
365 EXERCISE TOLERANCE DECREASED 2 0.0003
366 SKIN ATROPHY 2 0.0003
367 INJECTION SITE ERYTHEMA 43 0.0003
368 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
369 LOCAL SWELLING 6 0.0003
370 SKIN WARM 2 0.0003
371 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
372 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
373 PLEURISY 2 0.0003
374 WRONG DRUG ADMINISTERED 3 0.0003
375 PREGNANCY WITH CONTRACEPTIVE DEVICE 3 0.0003
376 ATYPICAL PNEUMONIA 1 0.0003
377 SYMPTOM RECURRENCE 2 0.0003
378 BLOOD CULTURE POSITIVE 1 0.0003
379 CRYING 12 0.0003
380 SUICIDAL IDEATION 30 0.0003
381 CHEST X-RAY ABNORMAL 1 0.0003
382 INJECTION SITE RASH 10 0.0003
383 RHINORRHOEA 21 0.0003
384 PROCEDURAL PAIN 9 0.0003
385 PIGMENTATION DISORDER 2 0.0003
386 CONJUNCTIVITIS 6 0.0003
387 ANXIETY 92 0.0003
388 PRODUCT DOSE OMISSION ISSUE 95 0.0003
389 MUSCULOSKELETAL CHEST PAIN 5 0.0003
390 ANKLE FRACTURE 5 0.0003
391 FLANK PAIN 3 0.0003
392 HEPATIC CIRRHOSIS 6 0.0003
393 URTICARIA 53 0.0003
394 THERAPEUTIC RESPONSE CHANGED 2 0.0003
395 BLADDER PAIN 1 0.0003
396 FEELING JITTERY 6 0.0003
397 NO ADVERSE EVENT 57 0.0003
398 HYPERSOMNIA 9 0.0003
399 OBESITY 5 0.0003
400 COVID-19 55 0.0003
401 COLITIS ULCERATIVE 14 0.0003
402 RASH PAPULAR 7 0.0003
403 ILLNESS 32 0.0003
404 CARDIAC FLUTTER 2 0.0003
405 INCOHERENT 2 0.0003
406 RESPIRATORY TRACT INFECTION 8 0.0003
407 POLYP 2 0.0003
408 THERAPY CHANGE 3 0.0003
409 KNEE OPERATION 3 0.0003
410 INCORRECT PRODUCT STORAGE 4 0.0003
411 BEDRIDDEN 4 0.0003
412 ACNE 23 0.0003
413 PRODUCT FORMULATION ISSUE 2 0.0003
414 SARS-COV-2 TEST POSITIVE 4 0.0003
415 DEPRESSED MOOD 16 0.0003
416 BLADDER DISORDER 3 0.0003
417 BLOOD CHOLESTEROL INCREASED 14 0.0003
418 OVARIAN CYST 3 0.0003
419 MUSCLE SPASMS 55 0.0003
420 PREGNANCY 6 0.0003
421 IRRITABILITY 18 0.0003
422 BLOOD POTASSIUM DECREASED 9 0.0003
423 PRODUCT PHYSICAL ISSUE 6 0.0003
424 DISTURBANCE IN ATTENTION 16 0.0003
425 VAGINAL DISCHARGE 3 0.0003
426 FREQUENT BOWEL MOVEMENTS 8 0.0003
427 EYE IRRITATION 17 0.0003
428 FLUID RETENTION 15 0.0003
429 PRODUCT LABEL ISSUE 2 0.0003
430 PULMONARY EMBOLISM 28 0.0003
431 MOTOR DYSFUNCTION 3 0.0003
432 FEELING HOT 18 0.0003
433 HEADACHE 184 0.0003
434 EYE MOVEMENT DISORDER 2 0.0003
435 ONYCHOCLASIS 2 0.0003
436 SURGERY 17 0.0003
437 DROOLING 2 0.0003
438 NASAL CONGESTION 17 0.0003
439 HAIR GROWTH ABNORMAL 2 0.0003
440 LARGE INTESTINE POLYP 2 0.0003
441 AUTOIMMUNE HEPATITIS 2 0.0003
442 WEIGHT FLUCTUATION 3 0.0003
443 INJECTION SITE DISCOMFORT 3 0.0003
444 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
445 APPLICATION SITE REACTION 2 0.0003
446 COLD SWEAT 5 0.0003
447 NEPHROLITHIASIS 13 0.0003
448 RENAL PAIN 3 0.0003
449 THERMAL BURN 2 0.0003
450 FEAR OF INJECTION 2 0.0003
451 ABDOMINAL PAIN 65 0.0003
452 DRY SKIN 37 0.0003
453 PANIC REACTION 2 0.0003
454 SKIN LACERATION 3 0.0003
455 FLUSHING 28 0.0003
456 NEEDLE ISSUE 8 0.0003
457 PANIC ATTACK 10 0.0003
458 APATHY 4 0.0003
459 IMPAIRED HEALING 9 0.0003
460 GASTROENTERITIS 4 0.0003
461 INTENTIONAL UNDERDOSE 2 0.0003
462 TOOTH FRACTURE 3 0.0003
463 BLINDNESS TRANSIENT 2 0.0003
464 DENTAL CARIES 3 0.0003
465 ALCOHOL USE 1 0.0003
466 CEREBRAL DISORDER 2 0.0003
467 SUNBURN 2 0.0003
468 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
469 SKIN INFECTION 3 0.0003
470 PARAESTHESIA 42 0.0003
471 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
472 CHRONIC SINUSITIS 1 0.0003
473 ANHEDONIA 7 0.0003
474 ANGER 9 0.0003
475 HEPATIC ENZYME INCREASED 18 0.0003
476 IMPAIRED DRIVING ABILITY 3 0.0003
477 DEPRESSION 60 0.0003
478 DERMATITIS CONTACT 3 0.0003
479 MICTURITION URGENCY 3 0.0003
480 ABDOMINAL PAIN UPPER 54 0.0003
481 DISSOCIATION 2 0.0003
482 PHARYNGEAL OEDEMA 4 0.0003
483 DEVICE RELATED INFECTION 4 0.0003
484 TENDONITIS 4 0.0003
485 POST PROCEDURAL HAEMORRHAGE 3 0.0003
486 BRAIN FOG 4 0.0003
487 SLEEP DISORDER 18 0.0003
488 DRUG SCREEN POSITIVE 2 0.0003
489 MENTAL DISORDER 11 0.0003
490 PRODUCT PRESCRIBING ERROR 6 0.0003
491 DIABETIC KETOACIDOSIS 6 0.0002
492 ARTERIOSPASM CORONARY 1 0.0002
493 NERVOUSNESS 13 0.0002
494 EYE PAIN 14 0.0002
495 LOCALISED INFECTION 6 0.0002
496 RHINITIS 2 0.0002
497 FRUSTRATION TOLERANCE DECREASED 2 0.0002
498 PRODUCT ADMINISTRATION ERROR 5 0.0002
499 NOCTURIA 3 0.0002
500 NEURALGIA 6 0.0002
501 RESTLESSNESS 9 0.0002
502 SUBSTANCE ABUSE 2 0.0002
503 THROAT IRRITATION 11 0.0002
504 BODY TEMPERATURE INCREASED 5 0.0002
505 ABNORMAL FAECES 2 0.0002
506 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
507 PHARYNGITIS 3 0.0002
508 CYST 3 0.0002
509 INJECTION SITE PAIN 74 0.0002
510 PEMPHIGUS 3 0.0002
511 DYSSTASIA 7 0.0002
512 NAUSEA 189 0.0002
513 PERICARDITIS 4 0.0002
514 KNEE ARTHROPLASTY 5 0.0002
515 MOUTH ULCERATION 5 0.0002
516 INJECTION SITE IRRITATION 3 0.0002
517 INADEQUATE ANALGESIA 2 0.0002
518 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
519 VITAMIN D DECREASED 2 0.0002
520 HYPOAESTHESIA 35 0.0002
521 DYSPEPSIA 23 0.0002
522 NASOPHARYNGITIS 43 0.0002
523 CARDIAC OPERATION 2 0.0002
524 APHASIA 7 0.0002
525 DIPLOPIA 6 0.0002
526 CHAPPED LIPS 1 0.0002
527 ASTHMA 26 0.0002
528 BONE CANCER 1 0.0002
529 VERTIGO 14 0.0002
530 ALOPECIA 45 0.0002
531 GROIN PAIN 2 0.0002
532 PRODUCT COMMUNICATION ISSUE 2 0.0002
533 LYMPHADENOPATHY 8 0.0002
534 LETHARGY 13 0.0002
535 HYPERHIDROSIS 29 0.0002
536 MATERNAL EXPOSURE DURING PREGNANCY 20 0.0002
537 GALLBLADDER DISORDER 4 0.0002
538 SNEEZING 5 0.0002
539 PAIN OF SKIN 6 0.0002
540 SYNOVITIS 4 0.0002
541 CHILLS 26 0.0002
542 FEELING ABNORMAL 53 0.0002
543 TOOTHACHE 4 0.0002
544 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
545 AKATHISIA 3 0.0002
546 END STAGE RENAL DISEASE 4 0.0002
547 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
548 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
549 DEEP VEIN THROMBOSIS 14 0.0002
550 PERSONALITY CHANGE 2 0.0002
551 ROAD TRAFFIC ACCIDENT 9 0.0002
552 APHONIA 3 0.0002
553 CHOLELITHIASIS 7 0.0002
554 SKIN EXFOLIATION 18 0.0002
555 INFLAMMATION 11 0.0002
556 HEART RATE INCREASED 21 0.0002
557 THROMBOSIS 17 0.0002
558 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
559 LIP SWELLING 7 0.0002
560 RED BLOOD CELL COUNT DECREASED 6 0.0002
561 PRODUCT USE IN UNAPPROVED INDICATION 52 0.0002
562 EYE INFLAMMATION 2 0.0002
563 EXPOSURE DURING PREGNANCY 13 0.0002
564 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
565 PULMONARY FIBROSIS 4 0.0002
566 LOWER LIMB FRACTURE 4 0.0002
567 APHAGIA 1 0.0002
568 CONTUSION 20 0.0002
569 ANOSMIA 3 0.0002
570 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
571 INFLUENZA LIKE ILLNESS 17 0.0002
572 EAR PAIN 4 0.0002
573 PRESYNCOPE 5 0.0002
574 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
575 VITAMIN D DEFICIENCY 2 0.0002
576 ORAL HERPES 4 0.0002
577 HYPERSENSITIVITY 38 0.0002
578 RASH 89 0.0002
579 LIVER INJURY 5 0.0002
580 BREATH SOUNDS ABNORMAL 1 0.0002
581 INSOMNIA 54 0.0002
582 SINUS DISORDER 4 0.0002
583 ABDOMINAL TENDERNESS 1 0.0002
584 ANEURYSM 1 0.0002
585 INFECTION 29 0.0002
586 ABORTION SPONTANEOUS 8 0.0002
587 HEART RATE DECREASED 7 0.0002
588 SEIZURE 23 0.0002
589 UNEVALUABLE EVENT 15 0.0002
590 FEEDING DISORDER 4 0.0002
591 DRY MOUTH 16 0.0002
592 TOOTH ABSCESS 2 0.0002
593 DRUG DISPENSING ERROR 3 0.0002
594 INFUSION RELATED REACTION 13 0.0002
595 BLISTER 11 0.0002
596 EAR DISCOMFORT 2 0.0002
597 THYROID DISORDER 3 0.0002
598 CEREBRAL ISCHAEMIA 1 0.0002
599 TOOTH LOSS 4 0.0002
600 UNINTENDED PREGNANCY 2 0.0002
601 FATIGUE 149 0.0002
602 MUSCULOSKELETAL PAIN 10 0.0002
603 PRURITUS 73 0.0002
604 GASTROINTESTINAL DISORDER 17 0.0002
605 VOMITING 89 0.0002
606 INJECTION SITE MASS 7 0.0002
607 INCONTINENCE 2 0.0002
608 BRONCHITIS 14 0.0002
609 IMPAIRED WORK ABILITY 4 0.0002
610 LIVER FUNCTION TEST INCREASED 4 0.0002
611 DYSPNOEA EXERTIONAL 7 0.0002
612 MUSCLE TIGHTNESS 3 0.0002
613 BACK PAIN 43 0.0002
614 BEHAVIOUR DISORDER 1 0.0002
615 COLITIS 7 0.0002
616 ADVERSE EVENT 17 0.0002
617 SOMNOLENCE 37 0.0002
618 PRODUCT PRESCRIBING ISSUE 4 0.0002
619 PAIN IN EXTREMITY 54 0.0002
620 WEIGHT INCREASED 41 0.0002
621 OESOPHAGITIS 2 0.0002
622 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
623 BLOOD GLUCOSE FLUCTUATION 2 0.0002
624 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
625 STAPHYLOCOCCAL INFECTION 6 0.0002
626 GASTROINTESTINAL PAIN 2 0.0002
627 INJECTION SITE NODULE 2 0.0002
628 PHOTOSENSITIVITY REACTION 3 0.0002
629 THERAPEUTIC RESPONSE DECREASED 11 0.0002
630 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
631 ILL-DEFINED DISORDER 11 0.0002
632 ARTHRALGIA 75 0.0002
633 VIRAL INFECTION 6 0.0002
634 FUNGAL INFECTION 6 0.0002
635 FEELING COLD 5 0.0002
636 GAIT INABILITY 6 0.0002
637 MALNUTRITION 2 0.0002
638 EYE PRURITUS 6 0.0002
639 INTESTINAL PERFORATION 2 0.0002
640 FISTULA 2 0.0002
641 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
642 DIZZINESS 88 0.0002
643 SCAB 2 0.0002
644 CARDIAC VALVE DISEASE 1 0.0002
645 MUSCULOSKELETAL DISCOMFORT 3 0.0002
646 TINNITUS 8 0.0002
647 SKIN DISCOLOURATION 8 0.0002
648 MUSCLE TWITCHING 4 0.0002
649 DELIRIUM 6 0.0002
650 PSORIATIC ARTHROPATHY 7 0.0002
651 RASH MACULAR 6 0.0002
652 MUSCULOSKELETAL STIFFNESS 15 0.0002
653 OSTEOPOROSIS 7 0.0002
654 CONSTIPATION 37 0.0002
655 HEAD DISCOMFORT 3 0.0002
656 COVID-19 PNEUMONIA 2 0.0002
657 PRODUCT QUALITY ISSUE 23 0.0002
658 PSYCHOTIC DISORDER 5 0.0002
659 DRUG ERUPTION 3 0.0002
660 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
661 ATAXIA 2 0.0002
662 CHOLECYSTITIS 2 0.0002
663 CONDITION AGGRAVATED 51 0.0002
664 PRODUCTIVE COUGH 8 0.0002
665 MEMORY IMPAIRMENT 23 0.0002
666 RASH ERYTHEMATOUS 8 0.0002
667 GASTROENTERITIS VIRAL 3 0.0002
668 COMPLICATION OF DEVICE REMOVAL 3 0.0002
669 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
670 RESTLESS LEGS SYNDROME 3 0.0002
671 ADRENAL INSUFFICIENCY 2 0.0002
672 RECTAL HAEMORRHAGE 7 0.0002
673 MUSCLE SPASTICITY 2 0.0002
674 TENDON RUPTURE 2 0.0002
675 GENERALISED OEDEMA 2 0.0002
676 ABDOMINAL DISCOMFORT 27 0.0002
677 PSORIASIS 21 0.0002
678 HAIR COLOUR CHANGES 2 0.0002
679 VISION BLURRED 22 0.0002
680 SWOLLEN TONGUE 5 0.0002
681 INJECTION SITE DISCOLOURATION 2 0.0002
682 PRODUCT STORAGE ERROR 14 0.0002
683 SECRETION DISCHARGE 2 0.0002
684 BLEPHAROSPASM 1 0.0002
685 FLATULENCE 9 0.0002
686 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
687 URINARY TRACT INFECTION 27 0.0002
688 PAIN 97 0.0002
689 MUSCLE ATROPHY 2 0.0002
690 MUSCULOSKELETAL DISORDER 3 0.0002
691 JOINT SWELLING 19 0.0002
692 DRUG DOSE OMISSION 26 0.0002
693 INCREASED APPETITE 3 0.0002
694 BURNING SENSATION 11 0.0002
695 POST PROCEDURAL COMPLICATION 3 0.0002
696 SEROTONIN SYNDROME 3 0.0002
697 MYDRIASIS 2 0.0002
698 THERAPY NON-RESPONDER 7 0.0002
699 GENITAL HAEMORRHAGE 2 0.0002
700 ERUCTATION 3 0.0002
701 PRESCRIBED OVERDOSE 3 0.0002
702 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
703 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
704 INJECTION SITE INDURATION 2 0.0002
705 CHOKING 3 0.0002
706 AMNESIA 10 0.0002
707 NODULE 2 0.0002
708 JOINT STIFFNESS 4 0.0002
709 ORAL CANDIDIASIS 2 0.0002
710 WHEEZING 9 0.0002
711 IMMUNE SYSTEM DISORDER 2 0.0002
712 ANKYLOSING SPONDYLITIS 2 0.0002
713 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
714 APPETITE DISORDER 1 0.0002
715 COMPLICATION OF DEVICE INSERTION 3 0.0002
716 EXPIRED PRODUCT ADMINISTERED 5 0.0002
717 HAIR TEXTURE ABNORMAL 2 0.0001
718 MALIGNANT MELANOMA 2 0.0001
719 FEAR 4 0.0001
720 DRUG EFFECT DECREASED 8 0.0001
721 TYPE 2 DIABETES MELLITUS 5 0.0001
722 BRONCHIECTASIS 1 0.0001
723 SINUS CONGESTION 2 0.0001
724 TASTE DISORDER 3 0.0001
725 PRODUCT TASTE ABNORMAL 2 0.0001
726 RASH PRURITIC 8 0.0001
727 OCULAR HYPERAEMIA 7 0.0001
728 LIMB INJURY 4 0.0001
729 WEIGHT DECREASED 41 0.0001
730 TREATMENT NONCOMPLIANCE 8 0.0001
731 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
732 ABNORMAL DREAMS 4 0.0001
733 ORAL DISCOMFORT 2 0.0001
734 DERMATITIS 3 0.0001
735 NECK PAIN 8 0.0001
736 WOUND 4 0.0001
737 CARPAL TUNNEL SYNDROME 2 0.0001
738 PERIPHERAL SWELLING 22 0.0001
739 DIARRHOEA 92 0.0001
740 DEVICE OCCLUSION 2 0.0001
741 HALLUCINATION, VISUAL 3 0.0001
742 OSTEOARTHRITIS 6 0.0001
743 PAIN IN JAW 4 0.0001
744 RETCHING 3 0.0001
745 CHEST PAIN 26 0.0001
746 PARAESTHESIA ORAL 2 0.0001
747 SWELLING FACE 9 0.0001
748 DEVICE DISLOCATION 6 0.0001
749 UNDERDOSE 10 0.0001
750 CHEST DISCOMFORT 14 0.0001
751 PALPITATIONS 16 0.0001
752 LABORATORY TEST ABNORMAL 4 0.0001
753 DEHYDRATION 18 0.0001
754 HEPATOTOXICITY 3 0.0001
755 DYSGEUSIA 10 0.0001
756 BONE LOSS 2 0.0001
757 DYSARTHRIA 5 0.0001
758 HEART RATE IRREGULAR 3 0.0001
759 HYPOAESTHESIA ORAL 2 0.0001
760 PANCREATITIS 7 0.0001
761 PRODUCT AVAILABILITY ISSUE 3 0.0001
762 INCORRECT DOSE ADMINISTERED 30 0.0001
763 DEVICE FAILURE 2 0.0001
764 ERYTHEMA 27 0.0001
765 HIP ARTHROPLASTY 2 0.0001
766 BOWEL MOVEMENT IRREGULARITY 1 0.0001
767 CONFUSIONAL STATE 21 0.0001
768 OEDEMA 7 0.0001
769 DELUSION 2 0.0001
770 COGNITIVE DISORDER 6 0.0001
771 DEVICE MALFUNCTION 9 0.0001
772 PYREXIA 44 0.0001
773 PRODUCT USE COMPLAINT 2 0.0001
774 ANAPHYLACTIC REACTION 7 0.0001
775 DRUG INTERACTION 20 0.0001
776 INTENTIONAL PRODUCT MISUSE 11 0.0001
777 INFLUENZA 14 0.0001
778 MULTIPLE SCLEROSIS 6 0.0001
779 MALAISE 55 0.0001
780 GAIT DISTURBANCE 24 0.0001
781 HAEMORRHAGE 13 0.0001
782 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
783 MYALGIA 21 0.0001
784 EXTRA DOSE ADMINISTERED 5 0.0001
785 MUSCULAR WEAKNESS 14 0.0001
786 OEDEMA PERIPHERAL 15 0.0001
787 DRUG INEFFECTIVE 160 0.0001
788 SKIN DISORDER 4 0.0001
789 POLLAKIURIA 5 0.0001
790 AGGRESSION 6 0.0001
791 ATRIAL SEPTAL DEFECT 1 0.0001
792 WITHDRAWAL SYNDROME 5 0.0001
793 CELLULITIS 6 0.0001
794 RENAL IMPAIRMENT 10 0.0001
795 CHRONIC KIDNEY DISEASE 9 0.0001
796 CANDIDA INFECTION 2 0.0001
797 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
798 PRODUCT COMPLAINT 3 0.0001
799 SWELLING 11 0.0001
800 SCAR 2 0.0001
801 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
802 GASTRIC DISORDER 4 0.0001
803 NIGHTMARE 4 0.0001
804 DEVICE DEFECTIVE 2 0.0001
805 TREMOR 19 0.0001
806 ARTHRITIS 9 0.0001
807 DEVICE USE ISSUE 2 0.0001
808 SYRINGE ISSUE 2 0.0001
809 BLOOD CALCIUM INCREASED 1 0.0001
810 GASTRITIS 3 0.0001
811 LYMPHOCYTE COUNT DECREASED 2 0.0001
812 VISUAL IMPAIRMENT 14 0.0001
813 THROAT TIGHTNESS 3 0.0001
814 LEUKOCYTOSIS 2 0.0001
815 PALLOR 3 0.0001
816 DYSPNOEA 62 0.0001
817 SKIN IRRITATION 5 0.0001
818 AGITATION 8 0.0001
819 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
820 OROPHARYNGEAL PAIN 10 0.0001
821 THINKING ABNORMAL 2 0.0001
822 PRODUCT USE ISSUE 20 0.0001
823 RHEUMATOID ARTHRITIS 12 0.0001
824 FOOT FRACTURE 2 0.0001
825 BLOOD URINE PRESENT 2 0.0001
826 HERPES ZOSTER 6 0.0001
827 HERNIA 2 0.0001
828 HAEMORRHOIDS 2 0.0001
829 KIDNEY INFECTION 2 0.0001
830 ACUTE MYOCARDIAL INFARCTION 3 0.0001
831 DISABILITY 2 0.0001
832 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
833 ABNORMAL BEHAVIOUR 4 0.0001
834 DISORIENTATION 4 0.0001
835 DEVICE ISSUE 9 0.0001
836 RESPIRATORY DISORDER 3 0.0001
837 INJECTION SITE HAEMORRHAGE 8 0.0001
838 SYNCOPE 10 0.0001
839 COUGH 28 0.0001
840 BRAIN INJURY 1 0.0001
841 HYPERTENSION 21 0.0001
842 DEVICE BREAKAGE 4 0.0001
843 INJURY ASSOCIATED WITH DEVICE 2 0.0001
844 THERAPY INTERRUPTED 7 0.0001
845 SKIN BURNING SENSATION 7 0.0001
846 DRUG-INDUCED LIVER INJURY 3 0.0001
847 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
848 HYPOTHYROIDISM 3 0.0001
849 EATING DISORDER 2 0.0001
850 BODY HEIGHT DECREASED 1 0.0001
851 BREAST CANCER METASTATIC 1 0.0001
852 PNEUMONIA 30 0.0001
853 BALANCE DISORDER 8 0.0001
854 DEVICE EXPULSION 6 0.0001
855 PRURITUS GENERALISED 2 0.0001
856 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
857 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
858 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
859 BACK INJURY 1 0.0001
860 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
861 ASPIRATION 1 0.0001
862 EYE DISORDER 3 0.0001
863 EMOTIONAL DISTRESS 11 0.0001
864 HAEMATOCHEZIA 5 0.0001
865 LIVER DISORDER 4 0.0001
866 ARTHROPATHY 5 0.0001
867 URINARY RETENTION 3 0.0001
868 ORAL PAIN 2 0.0001
869 CHROMATURIA 2 0.0001
870 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
871 OFF LABEL USE 77 0.0001
872 DECREASED APPETITE 20 0.0001
873 PLATELET COUNT DECREASED 9 0.0001
874 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
875 CEREBRAL HAEMORRHAGE 3 0.0001
876 LUNG DISORDER 4 0.0001
877 CARDIOMEGALY 1 0.0001
878 EPISTAXIS 6 0.0001
879 AGEUSIA 2 0.0001
880 HYPOPHAGIA 2 0.0001
881 HEPATITIS 2 0.0001
882 THERAPY CESSATION 4 0.0001
883 UNRESPONSIVE TO STIMULI 2 0.0001
884 EXPOSURE VIA SKIN CONTACT 2 0.0001
885 SPEECH DISORDER 4 0.0001
886 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
887 DEVICE DIFFICULT TO USE 5 0.0001
888 ADVERSE REACTION 1 0.0001
889 RENAL FAILURE 10 0.0001
890 BLOOD PRESSURE DECREASED 5 0.0001
891 HYPOTENSION 15 0.0001
892 BLOOD BILIRUBIN INCREASED 2 0.0001
893 DYSKINESIA 3 0.0001
894 DYSPHAGIA 7 0.0001
895 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
896 APPLICATION SITE RASH 1 0.0001
897 MENTAL STATUS CHANGES 2 0.0001
898 BLOOD PRESSURE INCREASED 11 0.0001
899 BLOOD TEST ABNORMAL 1 0.0001
900 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
901 HYPOACUSIS 3 0.0001
902 MOBILITY DECREASED 5 0.0001
903 DEVICE LEAKAGE 3 0.0001
904 ASTHENIA 26 0.0001
905 LIVER FUNCTION TEST ABNORMAL 2 0.0001
906 DYSPHONIA 4 0.0001
907 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
908 TACHYCARDIA 6 0.0001
909 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
910 PREMATURE BABY 2 0.0001
911 HALLUCINATION 5 0.0001
912 LACRIMATION INCREASED 2 0.0001
913 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
914 STOMATITIS 4 0.0001
915 EPILEPSY 2 0.0001
916 DRUG ADMINISTRATION ERROR 2 0.0001
917 HYPOKALAEMIA 3 0.0001
918 CEREBROVASCULAR ACCIDENT 11 0.0001
919 RENAL DISORDER 3 0.0001
920 BASAL CELL CARCINOMA 1 0.0001
921 ARRHYTHMIA 3 0.0001
922 HEAD INJURY 2 0.0001
923 FALL 21 0.0001
924 CYSTITIS 2 0.0001
925 ABSCESS 1 0.0001
926 LOSS OF CONSCIOUSNESS 8 0.0001
927 MOVEMENT DISORDER 2 0.0001
928 DRUG INTOLERANCE 6 0.0001
929 BACK DISORDER 1 0.0001
930 VISUAL ACUITY REDUCED 2 0.0001
931 COAGULOPATHY 1 0.0001
932 HYPERKALAEMIA 2 0.0001
933 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
934 BRADYCARDIA 3 0.0001
935 ADVERSE DRUG REACTION 5 0.0001
936 ACCIDENTAL OVERDOSE 2 0.0001
937 DYSURIA 2 0.0001
938 BLOOD GLUCOSE ABNORMAL 1 0.0001
939 SEPSIS 6 0.0001
940 INTESTINAL OBSTRUCTION 2 0.0001
941 BLOOD SODIUM DECREASED 1 0.0001
942 CONVULSION 3 0.0001
943 CHOLESTASIS 1 0.0001
944 HOSPITALISATION 8 0.0001
945 ACUTE RESPIRATORY FAILURE 1 0.0001
946 BONE PAIN 3 0.0001
947 CATARACT 3 0.0001
948 BLOOD PRESSURE ABNORMAL 1 0.0001
949 PLEURAL EFFUSION 3 0.0000
950 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
951 SEPTIC SHOCK 2 0.0000
952 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
953 DRUG WITHDRAWAL SYNDROME 4 0.0000
954 APPLICATION SITE PAIN 1 0.0000
955 ANGIOEDEMA 2 0.0000
956 PULMONARY OEDEMA 2 0.0000
957 BREAST CANCER 4 0.0000
958 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
959 ANAEMIA 8 0.0000
960 OVERDOSE 9 0.0000
961 BLOOD PRESSURE FLUCTUATION 1 0.0000
962 ABASIA 1 0.0000
963 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
964 ACUTE KIDNEY INJURY 6 0.0000
965 HAEMOGLOBIN DECREASED 4 0.0000
966 ANAPHYLACTIC SHOCK 1 0.0000
967 DRUG DOSE OMISSION BY DEVICE 3 0.0000
968 BREAST CANCER FEMALE 1 0.0000
969 OXYGEN SATURATION DECREASED 2 0.0000
970 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
971 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
972 BONE DENSITY DECREASED 1 0.0000
973 BLOOD GLUCOSE INCREASED 5 0.0000
974 DIABETES MELLITUS 2 0.0000
975 DRUG ABUSE 2 0.0000
976 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
977 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
978 DISEASE PROGRESSION 2 0.0000
979 BLOOD CREATININE INCREASED 1 0.0000
980 NEUTROPENIA 2 0.0000
981 CARDIAC FAILURE 1 0.0000
982 CARDIAC FAILURE CONGESTIVE 1 0.0000
983 CARDIAC ARREST 1 0.0000
984 ATRIAL FIBRILLATION 1 0.0000
985 DEATH 5 0.0000